Skip to main content
. 2024 Jan 25;11(2):37. doi: 10.3390/jcdd11020037

Table 2.

Differences between the RETAKO peripartum TTS and the literature peripartum TTS populations. The comparison included 6 patients from the RETAKO database and 32 from the literature review.

RETAKO Peripartum Takotsubo Syndrome (n = 6) The Literature Peripartum Takotsubo Syndrome (n = 32) p Value
Age (years) 38.3 ± 2.3 34.2 ± 5.0 0.056
Hypertension 1 (16.7%) 4 (15.4%) 0.938
Dislipidaemia 1 (16.7%) 1 (3.8%) 0.242
Diabetes Mellitus 0 (0%) 0 (0%) n/a
Smoker/Ex-smoker 1 (16.7%) 1 (3.8%) 0.098
Obesity 0 (0%) 4 (15.4%) 0.304
TTS Trigger Secondary form 5 (83.3%) 21 (80.8%) 0.885
Symptoms Angina 1 (16.7%) 8 (30.8%) 0.489
Dyspnea 5 (100%) 19 (73.1%) 0.197
Palpitations 2 (33.3%) 1 (3.8%) 0.026
Syncope 0 (0%) 0 (0%)
In-hospital
complications
Stroke 1 (16.7%) 1 (3.8%) 0.242
Bleeding 0 (0%) 1 (3.8%) 0.625
Renal failure 1 (16.7%) 0 (0%) 0.034
Embolic events 0 (0%) 0 (0%)
Maximum
Killip status
I 2 (33.3%) 11 (42.3%) 0.016
II 1 (16.7%) 0 (0%)
III 2 (33.3%) 1 (3.8%)
IV 1 (16.7%) 14 (53.8%)
LVEF 38.8 ± 13.6 35 ± 11.2 0.475
TTS pattern Typical 2 (33.3%) 10 (38.5%) 0.815
ECG
abnormalities
ST-segment elevation 0 (0%) 7 (26.9%) 0.15
ST-segment depression 1 (16.7%) 2 (7.7%) 0.497
Initial T-wave inversion 3 (50%) 8 (30.8%) 0.371
Follow-up complications 0 (0%) 0 (0%)
Deaths 0 (0%) 0 (0%)
Follow-up 1353.8 (296.2–2062.7) 131.8 (27.7–180.0) 0.003

Follow-up time is expressed as days (median) and interquartile range (IQR).